| Product Code: ETC7643046 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to see a high concentration of viral vector and vaccine import shipments, with the top exporting countries being the USA, UK, Germany, Metropolitan France, and Serbia. Despite a negative Compound Annual Growth Rate (CAGR) of -4.18% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024, dropping by -30.16%. This data suggests that while the market may have experienced challenges in recent years, there may be potential for stabilization or recovery in the near future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Viral Vector and Vaccine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Viral Vector and Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Viral Vector and Vaccine Market - Industry Life Cycle |
3.4 Ireland Viral Vector and Vaccine Market - Porter's Five Forces |
3.5 Ireland Viral Vector and Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Ireland Viral Vector and Vaccine Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Ireland Viral Vector and Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Ireland |
4.2.2 Growing investments in research and development of vaccines and viral vectors |
4.2.3 Technological advancements in the field of biotechnology and gene therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for vaccine approval and commercialization |
4.3.2 Limited manufacturing capacity for viral vectors and vaccines in Ireland |
4.3.3 High costs associated with the development and production of viral vectors and vaccines |
5 Ireland Viral Vector and Vaccine Market Trends |
6 Ireland Viral Vector and Vaccine Market, By Types |
6.1 Ireland Viral Vector and Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Adenovirus, 2022 - 2032F |
6.1.4 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Fowlpox Virus, 2022 - 2032F |
6.1.5 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Attenuated Yellow Fever, 2022 - 2032F |
6.1.6 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Vaccinia Virus Vectors, 2022 - 2032F |
6.2 Ireland Viral Vector and Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.2.3 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Biopharmaceutical Companies, 2022 - 2032F |
6.2.4 Ireland Viral Vector and Vaccine Market Revenues & Volume, By Others, 2022 - 2032F |
7 Ireland Viral Vector and Vaccine Market Import-Export Trade Statistics |
7.1 Ireland Viral Vector and Vaccine Market Export to Major Countries |
7.2 Ireland Viral Vector and Vaccine Market Imports from Major Countries |
8 Ireland Viral Vector and Vaccine Market Key Performance Indicators |
8.1 Research and development expenditure in the biotechnology sector |
8.2 Number of clinical trials conducted for viral vectors and vaccines in Ireland |
8.3 Adoption rate of advanced gene therapy techniques in the healthcare sector |
9 Ireland Viral Vector and Vaccine Market - Opportunity Assessment |
9.1 Ireland Viral Vector and Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Ireland Viral Vector and Vaccine Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Ireland Viral Vector and Vaccine Market - Competitive Landscape |
10.1 Ireland Viral Vector and Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Ireland Viral Vector and Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here